IL1B and systemic inflammatory response syndrome: The activation of this pathway promotes the transcription of many pro-inflammatory cytokines and adhesion molecules such as IL-1B, IL-6, TNF-α, etc. These inflammatory mediators further activate the body’s defense system, resulting in continuous excessive release of inflammatory mediators, and ultimately lead to systemic inflammatory response syndrome characterized by the destruction of cells themselves (Feng et al., 2018).